This essay has been submitted by a student. This is not an example of the work written by our professional essay writers.
In this report, a protocol for the preparation and analysis of DNA which permits more rapid and sensitive antenatal detection of sickle cell anaemia. Restriction enzyme MST II digested DNA was used to analyse by agarose gel electrophoresis. The 1.2-kb Î²A and 1.4-kb Î²S MST II fragments were well separated in agarose gel electrophoresis. Sickle cell disease is due to the substitution of valine for glutamic acid at position 6 of the beta globin chain. This substitution allows haemoglobin S molecules to polymerize when deoxygenated. The polymerized haemoglobin S distorts the erythrocyte into the characteristic 'sickle' shape. The sickling disorders are a group of inherited diseases of the haemoglobin molecule characterized by chronic haemolytic anaemia. It is important to identify couple at risk for an affected pregnancy. In addition, prenatal diagnosis aims to provide an accurate result as early in pregnancy as possible. Prerequisites include the characterisation of their disease causing mutations, obtaining foetal material promptly and safely and investigating the genotype of the foetal DNA based on the parental mutations.
Sickle cell disease is the most common genetic disorder to affect Blacks (Honig, 1996; Konotey, 1992; Sergeant, 1985). For most affected children, the parents are usually unaware of the presence of the disease (Bainbridge et al., 1985). In developed countries, newborn screening programmes have been established to ensure early diagnosis and thus early enrolment into a comprehensive healthcare programme (Githens et al., 1990; Vichinsky et al., 1988). As in developing countries, sickle cell disease is prevalent, newborn screening for sickle cell disease is needed. In contrast, with advances in management, pregnant women with sickle cell disease now survive to have children (Ntim et al., 2006). However, the pregnancies of women with severe sickle haemoglobinopathies are associated with a high incidence of maternal and perinatal morbidity and mortality. In this report, sickle cell gene analysis was performed by using agarose gel electrophoresis of digested genetic sequences (Atkin et al., 1998).
Human beta globin genes include embryonic (Îµ)-globin genes, fetal (Î³)-globin genes and human adult (Î²)-globin genes, which are found on the short arm of human chromosome 11 (Ley et al., 1984). Sickle cell anaemia, a human genetic disease, is the result of single base pair (adenine to thymine) change in the beta globin gene. Amino acid substitutions is the replacement of one of the three bases in the RNA adenine, A; guanine, G; cytosine,C; uracil, U. Sickle cell anaemia is corresponding to the sixth amino acid residue, in which changing of glutamic acid to valine in the beta globin protein (Steinberg, 1999), at the same time abolishes an MST II restriction site which spans codons 5 to 7. A mutation in a single base in the DNA sequence of a gene affects the hybridization of an oligonucleotide complementary to the region of the mutation (Conner et al., 1983). The beta globin genes arranged 5' to 3' in order of expression during development.
beta globin gene cluster chromosome 11.jpg
Figure : The representation of the globin gene loci, the beta globin locus. The two gamma globin genes are active during fetal growth and produce hemoglobin F; the "adult" gene, beta, takes over after birth.
The replacement of A by T at the 17th nucleotide of the gene for the beta chain of haemoglobin changes the codon GAG for glutamic acid to GTG which encodes valine. Thus the sixth amino acid chain becomes valine instead of glutamic acid. It gives rise to sickle cell disease in homozygotes because the modified chain has a tendency to crystallise at low oxygen concentration. In the case of sickle cell haemoglobin, the replacement of a negatively charged glutamic acid in the standard HbA beta-globin by a neutral valine in HbS results in a protein with a slightly reduced negative charge. In homozygous individuals, the HbA tetramer electrophoresis as a single fast band, and the HbS tetramer as a single slow band. Heterozygous individual comprises with both forms of the tetramer, and therefore runs as two bands.
Figure 2: Amino acid sequence of normal adult haemoglobin with glutamic acid in position 6 and mutant adult haemoglobin with valine in position 6.
Sickle cell disease is inherited in an autosomal recessive manner. Homozygosity for the sickle mutation (HbSS) is responsible for the most common and most severe variant of sickle cell disease (Platt et al., 1994). If one parent has sickle cell anaemia (SS) and the other has sickle cell trait, there is a 50% chance of a child being affected with sickle cell trait (AS). When both parents have sickle cell trait (AS), a child has a 25% chance of being affected sickle cell disease (SS) (Koch et al., 2000). HbAS is heterozygote for the Î²s globin with no symptoms of the disease.
The beta globin gene region includes two flanking MST II sites. Restriction enzyme MST II was showed by Yuet Wai Kan and Andrees Dozy in 1978. This enzyme cuts normal beta globin DNA at a particular site, it will not recognize DNA that contains the sickle cell mutation, and therefore will not cut the beta globin. MST II recognized the sequence CCTNAGG, in which N represented any nucleotide. Sickle cell disease is due to a single amino aicd mutation in the beta globin gene on chromosome 11 that changes CCTGAGG to CCTGTGG. The mutation of A to T which causes sickle cell anaemia also causes the loss of the recognition site for the restriction enzyme MST II (Wilson et al., 1982).
normal cell sickle cell.gif
Figure 3: Restriction Fragment Length Polymorphism (RFLP) resulting from beta globin gene mutation.
In the normal cell, the beta globin peptide is CCTGAGGAG, the sequence corresponding to 5th amino acid to 7th amino acids which can be recognized by the restriction enzyme Mst II.Â In the sickle cell, one base is mutated from A to T, making the site unrecognizable by Mst II.Â Thus, Mst II will generate 1.2 kb and 0.2 kb fragments in the normal cell, but generate 1.4 kb fragment in the sickle cell.Â
A restriction fragment length polymorphism (RFLP) is defined by an enzyme, which cuts the double stranded DNA at a particular sequence of bases, a probe, a labelled, complementary segment of DNA that will anneal to a portion of the digested sample, and a set of variable fragment length bands that appear on Southern blot (William, 2005). The use of RFLP analysis is to diagnose inherited genetic disease and to identify disease carriers. Restriction enzyme and genetic disease are linked if a polymorphic region is close to the area responsible for a disease. The polymorphic region which is capable of being cut with a restriction enzyme is known within the gene responsible for a disease (Saiki et al., 1985).
Figure 4: The sickle cell mutation destroys an MST II site and generates a disease-specific RFLP.
The MST II restriction nuclease recognizes the sequence CCTNAGG where N = A, C, G or T. A restriction site for MST II is found in the normal Î²A-globin allele but is destroyed by the sickle cell mutation. The nearest flanking MST II sites are located, respectively, 1.2 kb upstream in the 5â€²-flanking region of the Î²-globin gene and 0.2 kb downstream at the 3â€² end of the first intron. Conservation of these flanking sites results in the Î²A-associated (1.2 kb + 0.2 kb) MST II RFLP and the sickle cell-associated 1.4 kb MST II RFLP.
Patient B has mild anaemia regarding the case study above, low haemoglobin level, low blood cell count and low MCH. Haemoglobin S solubility test showed turbidity, positive solubility in patient B, and citrate agar electrophoresis test indicated the presence of sickle cell haemoglobin S and haemoglobin A. Patient B is a sickle cell trait pregnant woman. Sickle cell gene analysis has been suggested to identify the risk of passing on the disorder to the unborn child. Based on the migration of DNA fragments in agarose gel electrophoresis, one band was presented on S band, control A and sample E has the same migration DNA fragment, therefore sample E, the unborn child is sickle cell disease. In homozygous individuals, the HbA tetramer electrophoresis as a single fast band, and the HbS tetramer as a single slow band. In control B, three bands were presented, both HbS and HbA; this indicated that control B is a sickle cell trait, genotype HbSA in which sample D (Patient B) and sample F (father) has the same migration DNA fragments. Heterozygous individual comprises with both forms of the tetramer, and therefore runs as two bands. The unborn child has inherited both sickle cell genes from each parent.
In figure 5, the normal sample (control C) showed two bands in the agarose gel electrophoresis. In normal cell, the sequence corresponding to 5th to 7th amino acids of the beta globin peptide is CCTGAGGAG, which can be recognized by the restriction enzyme Mst II.Â In the sickle cell, one base is mutated from A to T, making the site unrecognizable by Mst II.Â Therefore, normal sample migrated more rapid compared to sickle cell sample.
In women with sickle cell disease, the entire pregnancy is a high risk period that warrants close monitoring. With improved medical care and the use of prophylactic penicillin, the frequency of sickle crises in pregnancy has decreased significantly; but they may still occur and constitute an obstetric emergency (Grossetti et al., 2009). Hematopoietic stem cell transplantation can cure sickle cell disease and repeated transfusions of red blood cells can greatly decrease disease severity. However, exchange transfusion may be indicated in women with a serious obstetric or haematological complication (Elsayegh and Shapiro, 2007).
The diagnosis of sickle cell disease is established by demonstrating the presence of significant quantities of HbS by cellulose acetate electrophoresis, isoelectric focusing (IEF), high performance liquid chromatography (HPLC) or DNA analysis. In this report, we discussed about the sickle cell gene analysis by using agarose gel electrophoresis. This method is the easiest way of separating and analyzing DNA. The purpose of the gel is to quantify the particular band of the given DNA. The DNA is visualised in the gel by addition of ethidium bromide under ultra violet lamp. It gives fluoresces reddish-orange colour in the presence of DNA (Lewis et al., 2006).DNA is negative charge nucleic acid molecules, it moves through an agarose matrix with an electric field (electrophoresis) to positive electrode. DNA molecules of different lengths separate, the shortest moving farthest. When DNA is treated with restriction enzymes, the DNA is cut into fragments of various sizes. These fragments can be separated in a gel on the bases on their electric charge and size.
Hydroxyurea is a treatment for sickle cell disease which is contraindicated in pregnancy. This treatment is only for adult. The use of hydroxyurea in the treatment of sickle cell disease is commonly attributed to its ability to increase production of foetal haemoglobin (Lanzkron et al., 2008). This may prevent the cells from becoming rigid and clogging the blood vessels. Besides, hydroxyurea is a cytotoxic agent which has the potential to cause life threatening cytopenia. In addition, this drug should not be used in patients likely to become pregnant. Therefore, each sickle cell anaemia patient must be evaluated carefully before hydroxyurea therapy is begun, and careful monitoring must continue while the patient is on this agent. If hydroxyurea therapy has any beneficial effects, patient is advice to continue to take the prescribed dose but this therapy is not a cure (Charache and Terrin, 1995).
Obstetric units have adopted prophylactic transfusion regimens to pregnant woman who is sickle cell anaemia. The basis for exchange transfusion is to decrease the concentration of haemoglobin S, thus increasing the overall oxygen carrying capacity of the blood, which in turn reduces the changes of sickling and hence tissue damage. However, the disadvantages of exchange transfusions include transfusion reaction, alloimmunisation and exposure to infection. Infants are usually started on a course of penicillin treatment that extends from infancy to age of six. This treatment is meant to ward off potentially fatal infections. Bone marrow transplant has been shown to cure sickle cell anaemia in severely affected children. Besides, there are indications for a bone marrow transplant such as stroke, chronic unrelieved pain and recurrent acute chest syndrome.
In conclusion, it is important to determine the genotype of an individual. The newborn screening for sickle cell disease and an improved awareness for antenatal screening will increase the detection of sickle cell disease in the population. This will allow the appropriate care and management to reduce the morbidity and mortality of sickle cell disease.